Perrigo Deal Makes Extraction-Resistant PSE A Two-Player Competition
Executive Summary
Via Highland Pharmaceuticals agreement, Perrigo snaps up the only tamper-resistant pseudoephedrine formulation still available for licensing. It now goes up against Bayer – but will beat the pharma giant to market.